SMYD3 and breast cancer: E2F-1 was shown to be involved in the transcriptional activation of the SMYD3 gene, and a variable number of tandem repeat polymorphisms of an E2F-1 binding element in the SMYD3 promoter region was considered as a risk factor for familial breast cancers [26].